Increased pressure effects w/ maprotiline or TCA. Possibility of severe hypertensive reaction w/ MAOI. Increased IOP w/ agents that stimulate α
1- & α
2-adrenergic receptors. Urinary difficulty or worsen smooth muscle contraction in the bladder neck w/ α
1-adrenergic receptor stimulators. Possibility of severe hypertensive reaction w/ stimulation of β
1-adrenergic receptors. Slight increases in blood glucose conc in patients w/ DM.